Introduction {#Sec1}
============

The RIIIS/J inbred mouse strain carries a spontaneous gain-of-function mutation that specifically switches the expression of β1,4-*N*-acetylgalactosaminyltransferase, B4GALNT2 (previously referred to as GALGT2), from the intestinal epithelial pattern seen in most mice to a vascular endothelial cell-specific pattern. Endothelial cell expression of B4GALNT2 leads to aberrant post-translational modification of endothelial-derived von Willebrand Factor (VWF) with subterminal GalNAc residues, resulting in accelerated clearance and low circulating VWF levels. This unique regulatory mutation was termed *Mvwf1*, for *Modifier of VWF 1* (Mohlke et al. [@CR17]).

Glycosyltransferases serve a critical role in post-translational modification of proteins and are generally either spatially or temporally restricted in their expression programs (Lowe and Marth [@CR11]). Up to 1% of mammalian genes are involved in glycosylation, and 16 human congenital disorders of coagulation have been described, several of which affect coagulation (Haltiwanger and Lowe [@CR9]; Marquardt and Denecke [@CR13]). The physiologic function of the murine *B4galnt2* gene and its human ortholog, *B4GALNT2*, are unknown (Montiel et al. [@CR18]), and *B4galnt2* knockout animals are viable and have no discernable phenotype under laboratory conditions (Lowe and Marth [@CR11]). Several spontaneous mutations altering the tissue specificity of a given gene's expression have been reported, generally resulting in either a change in developmental timing (Crossley et al. [@CR5]; Cunningham and Jane [@CR6]) or a shift from a spatially restricted to a more generalized pattern of expression (Bedell et al. [@CR3]; Duhl et al. [@CR7]; Duttlinger et al. [@CR8]). To our knowledge, *Mvwf1* is the only reported example of a regulatory mutation resulting in a switch in gene expression program from one tissue-specific pattern to another restricted tissue-specific pattern.

Dolichos biflorus (DBA) lectin detects terminal nonreducing GalNAc residues such as those generated by *B4galnt2*. We previously demonstrated that DBA lectin detects the *Mvwf1* switch in the *B4galnt2* gene expression program from intestine to vessel (Mohlke et al. [@CR17]). Ponder and Wilkinson ([@CR25]) surveyed DBA lectin staining patterns in ten inbred mouse strains, including RIII/Ro, an ancestor of the RIIIS/J inbred mouse strain. They described two distinct staining patterns, the first an intestinal epithelial-specific pattern present in eight of the strains surveyed (including C57BL/6) and the second a vascular endothelial-specific pattern in the inbred strains DDK and RIII/Ro. Ponder et al. ([@CR26]) subsequently expanded the DBA lectin survey and detected the RIII/Ro pattern in 3 of 29 strains.

We now report the analysis of sequences surrounding the *B4galnt2* gene from mice exhibiting the vascular endothelial-specific or gastrointestinal epithelial-specific *B4galnt2* expression programs. Our data suggest that the region responsible for the unique *Mvwf1* regulatory mutation likely lies within a 30-kb interval upstream of the *B4galnt2* structural gene. We identify a number of unrelated inbred mouse strains, including several wild-derived strains, that carry the same *Mvwf1* allele, suggesting that this locus may be under positive selection.

Materials and methods {#Sec2}
=====================

Animals {#Sec3}
-------

C57BL6/J, CASA/RkJ, LEWES/EiJ, PERA/EiJ, PERC/EiJ, RIIIS/J, RF/J, Sf/CamEiJ, SWR/J, and WSB/EiJ males 5-8 weeks old were obtained from The Jackson Laboratory (Bar Harbor, ME). DDK mice were a gift from Dr. C. Sapienza (Temple University). Idaho (Id) outbred wild-derived mice (Miller et al. [@CR14]) were provided by Dr. R. Miller (University of Michigan). All protocols employed were approved by the University Committee on Use and Care of Animals (UCUCA) at the University of Michigan.

Preparation of biological samples {#Sec4}
---------------------------------

DNA was either obtained directly from The Jackson Laboratory or prepared from frozen tissue as previously described (Nichols et al. [@CR22]). Total RNA was prepared as previously described (Mohlke et al. [@CR17]). Platelet-poor plasma was collected as previously described (Nichols et al. [@CR22]) and stored at -80°C until analysis. Formalin-fixed tissues were paraffin embedded by the Tissue Core of the University of Michigan Comprehensive Cancer Center. Frozen tissues from six wild-derived inbred strains (Supplementary Table 1) were purchased from RIKEN BioResources Center (Japan). Formalin-fixed tissues from the inbred wild-derived mouse strain WSA were provided by Dr. Michael Potter (NIH). Formalin-fixed, paraffin-embedded whole bowels from the inbred mouse strains MA, STS, and GR were provided by Dr. Marco Breuer (The Netherlands Cancer Institute).

RIIIS/J genomic sequencing {#Sec5}
--------------------------

Primers were designed to generate overlapping amplicons averaging 800--900 bp in length from the C57BL6/J mouse chromosome 11 build 35, which is publicly available at NCBI, using Primer3 (Rozen and Skaletsky [@CR27]). PCR products were purified as previously described (Mohlke et al. [@CR17]) and sequencing of both strands was performed at the University of Michigan DNA Sequencing Core. An RIIIS/J consensus sequence for each amplicon was assembled to create an RIIIS/J contig using Seqman Lasergene software (DNASTAR, Inc.). Large polymorphisms were confirmed by long-range PCR (Expand Long Template PCR System, Roche) per the manufacturer's instructions or Southern blot as previously described (Bahou et al. [@CR1]). The RIIIS/J genomic sequence assembly has been deposited at NCBI (GenBank accession number EF372924).

Genotyping {#Sec6}
----------

Screening of a panel of DNA from multiple inbred mouse strains (Supplementary Table 1) was performed using RIIIS/J polymorphisms 5 kb and 10 kb upstream of *B4galnt2* exon 1 by genomic PCR (primer sets 1 and 2 in Supplementary Table 2) using PfuTurboHotstart (Stratagene) for amplicons smaller than 3 kb or Expand Long Template PCR System (Roche) for amplicons larger than 3 kb per the manufacturer's instructions.

For a haplotype analysis, genomic sequencing was performed as described above (primer sets 1, 2, and 29--53 in Supplementary Table 2). Unrooted parsimony trees were generated for individual amplicons using PAUP v4.0 beta (bootstrap analysis, heuristic method, *n* = 1000 replicates) and used to define groups with similar sequences. A parsimony tree, distance tree, and neighbor-joining tree were similarly generated using ordered concatenated sequences with PAUP v4.0 beta.

Analysis for the Mvwf1 tissue-specific switch {#Sec7}
---------------------------------------------

DBA lectin staining was performed on formalin-fixed, paraffin-embedded tissues as previously described (Mohlke et al. [@CR17]) using HRP-DBA lectin (H-Y Labs, Inc.). Plasma VWF levels were determined by ELISA in triplicate as previously described (Mohlke et al. [@CR16]). Aliquots of pooled C57BL6/J plasma were used to generate a standard curve. VWF values for at least three individual animals were averaged to ascertain each strain's VWF level.

Bacterial artificial chromosomes (BACs) {#Sec8}
---------------------------------------

Three overlapping C57BL6/J BACs containing the *B4galnt2* gene (Fig. [1](#Fig1){ref-type="fig"}A) were obtained. The C57BL/6J BAC clone RP23-271O13 (B6 BAC-1, Fig. [1](#Fig1){ref-type="fig"}A) was identified by screening the RPCI-23 library segment 2 filters (Research Genetics) with a probe generated by PCR with primer set 25 (Supplementary Table 2) spanning exons 1 and 2 of the *B4galnt2* cDNA and 446 bp of 5′ upstream genomic sequence. The RP24-158F18 and RP24-247D8 BACs (B6 BAC-2 and B6 BAC-3 respectively, Fig. [1](#Fig1){ref-type="fig"}A) were identified to contain *B4galnt2* by genomic sequence alignments with the C57BL6/J mouse chromosome 11 build 35 (available at <http://www.ncbi.nlm.nih.gov>/). All three BACs were obtained from the BACPAC Resources Center (Oakland, CA). The integrity of the BAC inserts was confirmed by PCR for the presence of the previously described sequence tagged sites (STSs) (Mohlke et al. [@CR16]) that were predicted to lie within the regions of the BACs and by Hin*dIII*, Eco*RI*, and Spe*I* restriction digests. Fig. 1Schematic of the *Mvwf1* genomic region, BACs, and RIIIS/J sequence. A Schematic of the nonrecombinant interval between *D11Moh24* and *D11Moh4* (Mohlke et al. [@CR15]); the *B4galnt2* gene is shown in blue (distances are referenced to C57BL6/J). Genomic regions spanned by the inserts of the C57BL6/J (B6) and the RIIIS/J (R3) BAC transgenes are shown; blue regions identify the location of the *B4galnt2* structural gene within the BAC insert. The homologous genomic regions sequenced in RIIIS/J are indicated, with the region of high sequence divergence in red. **B** Plot of single nucleotide differences between RIIIS/J and C57BL6/J; the *B4galnt2* structural gene is annotated below the *x* axis. Larger genomic differences were deleted, resulting in an approximately 10-kb smaller interval in this analysis than the C57BL6/J genomic distance. The average sequence difference between inbred strains is 1%, indicated by the dashed black line. An approximately 30-kb region of high sequence divergence (dotted red box) flanks *B4galnt2* exon 1

An RIIIS/J BAC library was commissioned from BioS&T (Montreal, Quebec). The library was screened for BAC clones likely to contain the *B4galnt2* gene with a probe positioned 2 kb upstream of *B4galnt2* (primer set 28 in Supplementary Table 2). Two positive clones, C8 and H1 (R3 BAC-1 and R3 BAC-2 respectively, Fig. [1](#Fig1){ref-type="fig"}A), with unique insert sizes were identified using pulsed-field gel electrophoresis. End sequencing and alignment to C57BL6/J mouse chromosome 11 build 35 predicted both BACs to contain the entire *B4galnt2* gene (Fig. [1](#Fig1){ref-type="fig"}A). The integrity of the BAC inserts was confirmed by Hin*dIII* restriction digests, genomic PCR of 16 amplicons spanning the predicted genomic inserts (primer sets 8--23 in Supplementary Table 2), and Southern blots as previously described (Bahou et al. [@CR1]).

Transgenic animals {#Sec9}
------------------

BACs were purified using the NucleoBond BAC Maxi kit (Clontech). Transgenic mice were generated at the University of Michigan Transgenic Animal Model Core. Purified DNA was microinjected into fertilized eggs obtained from the mouse strains indicated below and pronuclear microinjection was performed as described (Nagy et al. [@CR21]). The B6 BAC-1 was injected into (*B4galnt2* knockout × SWR/J)F~1~ oocytes. The B6 BAC-2 and B6 BAC-3 were injected into SWR/J oocytes. R3 BAC-1 and R3 BAC-2 were injected into (C57BL/6 × SJL)F~2~oocytes. Founder animals were backcrossed to a *B4galnt2*-deficient background using a PCR-based genotyping strategy (all primers are in Supplementary Table 2) to identify the BAC vector (primer set 5), the *B4galnt2* null allele (primer set 6), and a 118-bp insertion present 5 kb upstream of *B4galnt2* on the SWR/J (*Mvwf1*) *B4galnt2* allele (primer set 7).

Results {#Sec10}
=======

RIIIS/J genomic sequence and structure {#Sec11}
--------------------------------------

RIIIS/J genomic sequence was obtained spanning a region homologous to 105 kb in C57BL6/J (annotated in Fig. [1](#Fig1){ref-type="fig"}) containing the entire *B4galnt2* structural gene, upstream intergenic region, and extending into the upstream gene *Igf2bp1*. An approximately 30-kb region of greater than 2--3% single nucleotide divergence from C57BL6/J was identified that flanks *B4galnt2* exon 1 (indicated in red in Fig. [1](#Fig1){ref-type="fig"}). In addition to single nucleotide differences (SNPs), this region also contains size variation in simple and complex tandem repeats as well as larger insertions and deletions. The net effect of these larger genomic changes decreases the size of the RIIIS/J upstream intergenic interval by 10 kb compared to C57BL6/J.

Survey of mouse strains for the *Mvwf1* allele and tissue-specific switch {#Sec12}
-------------------------------------------------------------------------

Ponder and Wilkinson ([@CR25]) previously described a switch in DBA lectin staining pattern from bowel to vessel similar to *Mvwf1* in several inbred mouse strains, including the RIII strain from which RIIIS/J is descended. Thus, *Mvwf1* may be present in inbred mouse strains other than RIIIS/J. DNA from 59 inbred strains (Supplementary Table 1) was screened for the *Mvwf1* allele using two size polymorphisms 5 and 10 kb upstream of *B4galnt2* exon 1, including all available descendants of the strains described by Ponder et al. ([@CR26]). Thirteen unrelated (Beck et al. [@CR2]) inbred strains carrying the *Mvwf1* allele were identified (Table [1](#Tab1){ref-type="table"}), including five independent wild-derived strains. The presence of the *Mvwf1* allele in wild-derived strains suggests that *Mvwf1* may also be present in wild mouse populations. Alternatively, accidental genetic contamination, which has been documented to occur between conventional inbred strains (Naggert et al. [@CR20]), could explain distribution of a single rare mutant allele among multiple laboratory strains. To test this hypothesis, DNA from recently established wild-derived outbred mouse colonies maintained by Dr. R. Miller at the University of Michigan Miller et al. [@CR14]) was screened for the *Mvwf1* allele. *Mvwf1* polymorphisms were found in individuals from two distinct wild-derived *M. m. domesticus* colonies, implying that the *Mvwf1* allele is present in the wild mouse populations from which these mice were derived. Table 1Mouse strain phenotypesStrain ID\#Strain nameDBA lectin staining patternPlasma VWF + /-1 SD (arbitrary units)2.7-kb del (15 kb upstream)6.4-kb del (10 kb upstream)120-bp ins (5 kb upstream)1129x1/SvJbowel+, vessel-ndndwtwt2A/Jbowel+, vessel-ndndwtwt9C57BL/6Jbowel+, vessel-ndwtwtwt15CASA/RkJ^a^bowel+, vessel-18.87 + /−2.37ndnrwt24DDKbowel-, vessel+1.47 + /−0.80nddelins26GRbowel-, vessel+ndndndins28Id12b^b^bowel+, vessel-ndndndwt29Ih12b^b^bowel-, vessel+ndndndins32KK/H1Jbowel-, vessel+6.26 + /−0.74deldelins33LEWES/EiJ^a^bowel-, vessel+3.65 + /−0.32deldelins35MAbowel-, vessel+ndndndins37MOLF/EiJ^a^bowel+, vessel-17.81 + /−0.80wtnrwt46PERA/EiJ^a^bowel-, vessel+1.70 + /−0.61deldelins47PERC/EiJ^a^bowel-, vessel+11.72 + /−1.67deldelins51RF/Jbowel-, vessel+3.53 + /−1.00deldelins52RIIIS/Jbowel-, vessel+2.36 + /−0.18deldelins53SF/CamEiJ^a^bowel-, vessel+2.48 + /−0.22deldelins60SWR/Jbowel-, vessel+nddeldelins63WSA^a^bowel-, vessel+nddelndins64WSB/EiJ^a^bowel-, vessel-22.35 + /−1.52wtdelins\*Data for mouse strains for small-bowel DBA lectin staining pattern, plasma VWF level, and corresponding results of the screen by PCR for RIIIS/J size polymorphisms: wt = wild-type (similar to C57BL6/J); ins\* = intermediate PCR size with *Mvwf1* SNPs; del = deletion, ins = insertion; nd = not determined; nr = no results^a^Wild-derived inbred mouse strains^b^From recently derived outbred *M. m. domesticus* colonies

To confirm that the presence of the *Mvwf1* allele, as detected by the presence of two RIIIS/J polymorphisms described above, corresponds to the *Mvwf1* tissue-specific switch, DBA lectin staining was performed on bowels from the 13 strains identified above and plasma VWF levels were determined for the nine available strains maintained at The Jackson Laboratory. DBA lectin detects *B4galnt2*-specific subterminal GalNAc residues, as demonstrated by the absence of DBA lectin staining in any tissues from *B4galnt2* knockout animals. All 13 *Mvwf1* strains exhibited a vessel(+), bowel(--) DBA lectin staining pattern identical to RIIIS/J (Table [1](#Tab1){ref-type="table"}). A homozygote for the *Mvwf1* allele from Dr. Miller's wild-derived colony also exhibited the RIIIS/J lectin staining pattern. A survey of plasma VWF antigen levels from nine *Mvwf1* strains and three non-*Mvwf1* wild-derived strains (Table [1](#Tab1){ref-type="table"}) found that the *Mvwf1* strains have low VWF levels relative to the three non-*Mvwf1* wild-derived strains, consistent with a decrease in VWF level due to vascular endothelial *B4galnt2* expression, as previously demonstrated for RIIIS/J (Mohlke et al. [@CR15]).

Characterization of a highly conserved*Mvwf1* haplotype block {#Sec13}
-------------------------------------------------------------

Genomic sequencing from 13 regions with an average amplicon length of approximately 800 bp was performed over a 55-kb genomic region encompassing the approximately 30-kb region of high sequence divergence (see Supplementary Table 3 for a summary of the number of SNPs at each amplicon). Nine *Mvwf1* strains and wild-derived inbred strains from the *M. musculus* clade (Tucker [@CR28]), *M. spretus*, and *M. spicilegus* were included in this analysis. All nine of the *Mvwf1* strains surveyed were found to share a unique, highly conserved common haplotype block spanning the entire region that was distinct from all other strains tested (represented in Fig. [2](#Fig2){ref-type="fig"}; amplicons with *Mvwf1* SNPs are yellow; the haplotype block is outlined by the solid black box). Refinement of the haplotype data effort by sampling sequence from ten additional regions (5 upstream and 5 downstream) determined that the shared *Mvwf1* haplotype block is approximately 97kb in length and encompasses the entire upstream intergenic region and most of the *B4galnt2* structural gene. Seven of 20 non-*Mvwf1* mouse strains surveyed were found to share two or more contiguous SNP blocks identical to the *Mvwf1* haplotype (highlighted in the red boxes in Fig. [2](#Fig2){ref-type="fig"}), suggesting recombined alleles partially derived from the *Mvwf1* founder allele. To determine if these shared regions affect *B4galnt2* tissue-specific expression, DBA lectin staining was performed on bowel from strains representative of each candidate recombined haplotype pattern (Table [1](#Tab1){ref-type="table"}). MOLF/EiJ (Strain ID \#37) and Id12b (Strain ID \#28) both exhibit a wild-type gut(+), vessel(−) pattern, suggesting that the genomic region responsible for the *Mvwf1* tissue-specific switch in *B4galnt2* gene expression program lies upstream of the *B4galnt2* structural gene and proximal promoter region (boundary indicated in Fig. [2](#Fig2){ref-type="fig"} by the black dashed line within the *Mvwf1* haplotype block). DBA lectin staining was absent in both bowel and vessel in WSB/EiJ (Strain ID \#64), suggesting the presence of an independent *B4galtnt2* loss-of-function mutation on this allele. Fig. 2*Mvwf1* haplotype block. A highly conserved *Mvwf1* haplotype block (yellow) is shared by the *Mvwf1* inbred strains and distinct from other wild-derived inbred strains representative of the *M. m. musculus* clade, *M. spretus*, and *M. spicilegus*. Strain ID numbers are indicated on the left (see Supplementary Table [1](#Tab1){ref-type="table"}). Colors were assigned to similar sequences based upon PAUP phylogeny trees; missing data are white. The *B4galnt2* exon 1 boundary is highlighted by the thick white vertical line. The *Mvwf1* haplotype block is outlined in black. Shorter segments in seven additional strains (28, 64, 37, 38, 40, 31, 20) have two or more contiguous amplicons with sequence identity to the *Mvwf1* strains (outlined in the red boxes)

BAC transgenes confer tissue-specific*B4galnt2* expression {#Sec14}
----------------------------------------------------------

A strain-specific overlapping BAC transgene strategy (Fig. [1](#Fig1){ref-type="fig"}A) with inserts derived from either the C57BL6/J (intestine+) mouse strain or the RIIIS/J (vessel+) mouse strain was used to identify a minimal genomic interval that contains intestine- and/or vessel-specific regulatory elements. All three C57BL6/J BAC transgenes restored an intestinal DBA lectin staining pattern in *B4galnt2*-deficient animals (Fig. [3](#Fig3){ref-type="fig"}), suggesting that the critical regulatory elements required for intestinal epithelial-specific expression are contained within the 84-kb overlapping region shared by the three BACs. Both RIIIS/J BAC transgenes restored a vascular expression pattern (Fig. [3](#Fig3){ref-type="fig"}), suggesting that the critical regulatory elements necessary for the vascular endothelial-specific expression program are contained within the 108-kb overlapping genomic region shared by these two BACs. Taken together, these data suggest that a master regulatory region may be localized to the genomic interval shared by these five BACs. Fig. 3BAC transgenic bowel DBA lectin staining. DBA lectin staining of small bowel; positive lectin staining is brown. **A** Lectin-stained bowel from C57BL6/J and F~1~ transgenic animals generated with each of the C57BL6/J BACs (vessels are positive from the endogenous *B4galnt2* gene; F~2~ transgenic *B4galnt2*-/- animals exhibit staining in bowel but not vessels, while *B4galnt2-/-* animals exhibit no staining in any tissue, data not shown). **B** Lectin-stained bowel from transgenic animals generated with the two RIIIS/J BACs and a transgene negative (Tg-) littermate. The endogenous gene confers intestinal staining in all animals. Arrows indicate serosal blood vessels

Discussion {#Sec15}
==========

The inbred mouse strain RIIIS/J exhibits a tissue-specific switch in the expression of β1,4-*N*-acetylgalactosaminyltransferase, or B4GALNT2, from the intestinal epithelial pattern seen in most mice to a vascular endothelial cell-specific pattern (Mohlke et al. [@CR17]). Examples of regulatory mutations in other genes have been previously reported, which change either temporal or spatial gene expression programs. Although large genomic rearrangements such as those resulting from chromosome translocations can also result in tissue-specific switches in gene expression programs by moving genes from their native genomic context to another differentially regulated locus, previous work (Mohlke et al. [@CR17]) and our current data exclude such a large genomic rearrangement as a mechanism for the *Mvwf1* switch. In humans, diseases such as hereditary persistence of fetal hemoglobin (Cunningham and Jane [@CR6]) can result from mutations that alter the timing of gene expression during development, although tissue specificity generally remains unchanged. Spontaneous mutations have been reported in mice that specifically decrease gene expression in the "normal" tissue while upregulating gene expression in other tissues, including examples such as the *W-sash* allele affecting c-kit (Duttlinger et al. [@CR8]) and the *Steel-contrasted* allele of the melanocyte growth factor gene (Bedell et al. [@CR3]). However, in these cases the gene expression pattern has been changed from a restricted tissue-specific pattern to a more ubiquitous pattern of gene expression. In contrast, the *Mvwf1* regulatory mutation results in a unique switch in gene expression program from one tissue-specific pattern to another entirely distinct tissue-specific expression program.

Previous work demonstrated that *Mvwf1* results from a *cis-*acting mutation (Mohlke et al. [@CR17]) genetically localized to a large 264-kb genomic interval surrounding the *B4galnt2* gene and containing nine flanking genes (Mohlke et al. [@CR15]). Although the use of alternative tissue-specific promoters has been described as a mechanism for regulating tissue-specific gene expression (Morishita et al. [@CR19]), 5′-RACE analysis appears to exclude this explanation for the *Mvwf1* regulatory switch. Taken together, the BAC expression data and multiple-strain analyses reported here (summarized in Fig. [4](#Fig4){ref-type="fig"}) refine the candidate interval for the *Mvwf1* regulatory mutation from the previous 264-kb genomic segment to a 30-kb intergenic region upstream of the *B4galnt2* structural gene. These results position the candidate region for the *Mvwf1* regulatory mutation well outside of the *B4galnt2* structural gene and proximal promoter region and suggest that the *Mvwf1* mutation alters the function of one or more enhancer and/or repressor elements acting over a large genomic distance. Fig. 4Summary of the *Mvwf1* candidate region. The genomic regions defined by the BAC transgenic experiments (RIIIS/J BACs in orange, C57BL6/J BACs in green), haplotype block analysis (red), and RIIIS/J genomic region of high sequence divergence (maroon hatch marks) are shown. The deduced 30-kb *Mvwf1* candidate interval is indicated in black

The genomic sequence within this region contains an approximately 30-kb region of strikingly high sequence divergence (\>2--3%) in RIIIS/J compared to C57BL6/J that flanks *B4galnt2* exon 1. This degree of sequence divergence is 3- to 30-fold greater than the sequence difference expected between modern laboratory strains (Wade et al. [@CR29]). This 30-kb segment lies within a conserved 97-kb haplotype block shared by all 13 inbred mouse strains shown to exhibit the *Mvwf1* switch in DBA lectin staining pattern from bowel to vessel first described by Ponder and Wilkinson ([@CR25]). Our data identify the cause of the *Mvwf1* tissue-specific switch in the *B4galnt2* gene expression program (and the resulting low circulating VWF levels) as a single, highly conserved *Mvwf1* founder allele that is common among inbred laboratory mouse strains. Six of these *Mvwf1* strains were included in a survey of coagulation parameters as part of the Mouse Phenome Database project (Peters and Barker [@CR24]), accounting for six of the seven longest activated partial thromboplastin times (aPTTs) reported in the database (Fig. [5](#Fig5){ref-type="fig"}). Thus, *Mvwf1* is a common allele among inbred mouse strains and the major cause of a prolonged aPTT in laboratory mice. Fig. 5Mouse Phenome Database: aPTT data. The six *Mvwf1* strains in the Mouse Phenome Database (Peters and Barker [@CR24]) are indicated by the red box

The identification of *Mvwf1* in multiple conventional inbred strains suggested that this allele may have been present in the *Mus musculus* clade from which the conventional inbred mouse strains were derived. Indeed, several of the *Mvwf1* strains reported here are wild-derived mouse strains that were created and maintained independent from conventional inbred laboratory mouse strains, supporting the persistence of *Mvwf1* specifically in the wild *M. m. domesticus* populations from which these wild-derived strains are descended (LEWES/EiJ was derived from founders trapped in Delaware, PERA/EiJ and PERC/EiJ from Peru, Sf/CamEiJ from California, and WSA from Maryland). The identification of *Mvwf1* in two independent and recently derived outbred wild mouse colonies from Idaho suggests that the *Mvwf1* allele continues to be maintained in contemporary wild mouse populations.

The existence of such a highly divergent, polymorphic genomic segment within a single species is quite unusual and raises interesting questions about the genetic origin of the *Mvwf1* allele. Although there are differences in the sizes of tandem repeats within this region between the *Mvwf1* strains, *Mvwf1* single nucleotide differences are nearly perfectly conserved. The conservation of single nucleotide differences is also shared by the wild-derived *Mvwf1* mouse strains. The existence of this highly conserved region within *M. m. domesticus* could be the result of selection, of suppression of recombination, or of a founder event. Indeed, the presence of a genomic region of such high nucleotide divergence is suggestive of balancing selection at or near this locus (Charlesworth [@CR4]). Alternatively, this divergent segment could have arisen as the result of an introgression event from a closely related species such as other members of the genus *Mus* (Lundrigan et al. [@CR12]). There is evidence that fragments of genomic DNA can be exchanged between mammalian species, including *M. spretus*, which is sympatric with *M. m. domesticus* (Hardies et al. [@CR10]; Orth et al. [@CR23]). A recently introduced foreign allele would be expected to have had less time to accrue sequence changes and could account for the large size of the *Mvwf1* haplotype block. If the *Mvwf1* divergent region is the result of an introgression event, then the species from which this allele was originally derived might also exhibit the phenotype conferred by the *Mvwf1* regulatory mutation.

Regardless of its origin, the presence of the highly conserved *Mvwf1* haplotype block among multiple, independent, wild-derived inbred strains, the diversity in geographic location and temporal spacing of capture of the original wild-derived strain founder mice, and the presence of the *Mvwf1* allele in recently derived outbred mouse colonies are all consistent with the maintenance of the *Mvwf1* allele as a natural variant in wild *M. m. domesticus* populations. Taken together, these data suggest the possibility that the *Mvwf1* phenotype may confer a fitness advantage, resulting in selective pressure that accounts for the prevalence of the *Mvwf1* allele in wild mouse populations. Even if additional evidence for natural selection can be obtained, the underlying mechanism may be difficult to precisely define. A direct effect of reduced plasma VWF (perhaps via decreased thrombotic risk) is one possibility. However, the responsible protein could also be any of the large number of other endothelial protein products (in addition to VWF) that are likely to be altered by *Mvwf1.* It is also possible that loss of GI epithelial *B4galnt2* expression, rather than gain of endothelial expression, confers a fitness advantage in wild mouse populations. If the underlying explanation is indeed reduced plasma VWF, then similar positive selective pressures may have contributed to the high prevalence of von Willebrand disease in multiple mammalian species, including humans.
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